MIRA Pharmaceuticals, Inc. (MIRA)

USD 1.05

(-1.87%)

Revenue Summary of MIRA Pharmaceuticals, Inc.

  • MIRA Pharmaceuticals, Inc.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • MIRA Pharmaceuticals, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • MIRA Pharmaceuticals, Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • MIRA Pharmaceuticals, Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • MIRA Pharmaceuticals, Inc. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • MIRA Pharmaceuticals, Inc. reported a quarterly revenue of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Historical Annual Revenue of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%

Peer Revenue Comparison of MIRA Pharmaceuticals, Inc.

Name Revenue Revenue Difference
Amgen Inc. 28.19 Billion USD 100.0%
AstraZeneca PLC 45.81 Billion USD 100.0%
Biogen Inc. 9.83 Billion USD 100.0%
Gilead Sciences, Inc. 27.11 Billion USD 100.0%
Scilex Holding Company 46.74 Million USD 100.0%
Scilex Holding Company 46.74 Million USD 100.0%